Eli Lilly Opens Compassionate Use Pathway For Patients Needing Experimental Obesity Drug
To qualify for retatrutide special use, patients must be at least 18, unable to take part in a clinical trial, have refractory obesity and two or more serious obesity-related complications, and have discussed all standard treatment options, Stat reported. Plus, two studies found no evidence linking MMR shots or circumcision to autism.